Sanger, Illumina Team Sequences Tasmanian Devil Genome

At a conference in Australia today, researchers from Illumina and the Wellcome Trust Sanger Institute announced that they have sequenced the Tasmanian devil genome, along with tumor genomes representing a contagious cancer decimating wild devil populations.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.